Abstract:As the size of accessible compound libraries expands to over 10 billion, the need for more efficient structure-based virtual screening methods is emerging. Different pre-screening methods have been developed for rapid screening, but there is still a lack of structure-based methods applicable to various proteins that perform protein-ligand binding conformation prediction and scoring in an extremely short time. Here, we describe for the first time a deep-learning framework for structure-based pharmacophore modeling to address this challenge. We frame pharmacophore modeling as an instance segmentation problem to determine each protein hotspot and the location of corresponding pharmacophores, and protein-ligand binding pose prediction as a graph-matching problem. PharmacoNet is significantly faster than state-of-the-art structure-based approaches, yet reasonably accurate with a simple scoring function. Furthermore, we show the promising result that PharmacoNet effectively retains hit candidates even under the high pre-screening filtration rates. Overall, our study uncovers the hitherto untapped potential of a pharmacophore modeling approach in deep learning-based drug discovery.

What problem does this paper attempt to address?

The main objective of this paper is to propose a new deep learning framework—PharmacoNet, aimed at accelerating the process of large-scale virtual screening (VS). Specifically, PharmacoNet aims to address the following key issues: 1. **Improving Virtual Screening Efficiency**: With the dramatic increase in the size of accessible compound libraries, reaching the scale of billions, traditional structure-based virtual screening methods become inefficient in handling such large compound libraries. Therefore, more efficient methods need to be developed to screen these compounds. 2. **Application of Structure-Based Methods**: Existing rapid prescreening methods often lack effective applicability to multiple proteins and struggle to complete protein-ligand binding conformation prediction and scoring in a very short time. PharmacoNet aims to improve this situation through deep learning technology. 3. **Binding Conformation Prediction and Scoring**: Traditional molecular docking methods require generating a large number of initial ligand conformations' binding poses and using complex physical energy equations for scoring, leading to high computational costs. PharmacoNet simplifies the model by using pharmacophore-based rapid evaluation. 4. **Maintaining Hit Candidates**: Under high filtration rates, traditional prescreening methods may miss potential hit candidates. PharmacoNet has designed a new method that effectively retains these candidates, ensuring a high hit rate even under high filtration rates. To achieve the above goals, PharmacoNet adopts the following strategies: - **Pharmacophore Modeling**: Transforming the pharmacophore modeling problem into an instance segmentation problem to determine protein hotspots and their corresponding pharmacophore locations. This helps in quickly identifying pharmacophore features related to protein function. - **Binding Pose Prediction**: Transforming the protein-ligand binding pose prediction problem into a graph matching problem, thereby avoiding complex atomic-level calculations. - **Scoring Function**: Introducing a new scoring function based on pharmacophore distance probability to evaluate the matching degree between the ligand and the pharmacophore model. Experimental results show that PharmacoNet significantly improves speed compared to traditional molecular docking methods while maintaining reasonable accuracy. Additionally, PharmacoNet effectively retains hit candidates in large-scale virtual screening, demonstrating good performance even under high filtration rates.

PharmacoNet: Accelerating Large-Scale Virtual Screening by Deep Pharmacophore Modeling

PharmacoNet: deep learning-guided pharmacophore modeling for ultra-large-scale virtual screening

PharmacoMatch: Efficient 3D Pharmacophore Screening through Neural Subgraph Matching

Structure-based pharmacophore modeling 1. Automated random pharmacophore model generation

PharmRL: Pharmacophore elucidation with Deep Geometric Reinforcement Learning

PIGNet2: A Versatile Deep Learning-based Protein-Ligand Interaction Prediction Model for Binding Affinity Scoring and Virtual Screening

An artificial intelligence accelerated virtual screening platform for drug discovery

Deep Learning-Based Modeling of Drug–Target Interaction Prediction Incorporating Binding Site Information of Proteins

Machine Learning-Enabled Pipeline for Large-Scale Virtual Drug Screening

Accurate prediction of protein–ligand interactions by combining physical energy functions and graph-neural networks

Evaluation of network architecture and data augmentation methods for deep learning in chemogenomics

ParaVS: A Simple, Fast, Efficient and Flexible Graph Neural Network Framework for Structure-Based Virtual Screening

Structure-Based Drug Design with a Deep Hierarchical Generative Model

One-step Structure Prediction and Screening for Protein-Ligand Complexes using Multi-Task Geometric Deep Learning

PharML.Bind: Pharmacologic Machine Learning for Protein-Ligand Interactions

Machine learning accelerates pharmacophore-based virtual screening of MAO inhibitors

Large-scale Pretraining Improves Sample Efficiency of Active Learning based Molecule Virtual Screening

An open-source drug discovery platform enables ultra-large virtual screens

DFRscore: Deep Learning-Based Scoring of Synthetic Complexity with Drug-Focused Retrosynthetic Analysis for High-Throughput Virtual Screening

Deep Learning in Virtual Screening: Recent Applications and Developments

Validation of Deep Learning-Based DFCNN in Extremely Large-Scale Virtual Screening and Application in Trypsin I Protease Inhibitor Discovery